Through Kaplan-Meier survival analyses, we additionally determined that elevated DTYMK expression was associated with decreased overall survival (OS) in HCC patients (p = 0.0316; Figure 1E), and this finding was supported by prognostic assessments of the GEPIA2 and UALCAN datasets which confirmed that elevated DTYMK expression was associated with poorer OS (Supplementary Figures 1B, C). Here, DTYMK is linked to hepatocellular carcinoma.